SCHEMBL12379218

SCHEMBL12379218

CC(C)n1cnc2c(N)nc(I)nc21

nearest known ligand 0.71

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ CDK1 P06493 17/20 0.71
▸ CDK2 P24941 4/20 0.71
▸ CCNB1 P14635 2/20 0.71
▸ CCNE1 P24864 2/20 0.71
▸ ADORA2A P29274 2/20 0.58
▸ ADORA2B P29275 2/20 0.58
▸ ADORA1 P30542 2/20 0.58
▸ PI4KA P42356 1/20 0.58
▸ PI4K2B Q8TCG2 1/20 0.58
▸ PI4K2A Q9BTU6 1/20 0.58
▸ PI4KB Q9UBF8 1/20 0.58
▸ CDK5 Q00535 2/20 0.52
▸ ADORA3 P0DMS8 1/20 0.44
▸ PRKACA P17612 1/20 0.42
▸ CCNA2 P20248 1/20 0.42
▸ PRKACG P22612 1/20 0.42
▸ PRKACB P22694 1/20 0.42
▸ MAPK3 P27361 1/20 0.42
▸ MAPK1 P28482 1/20 0.42
▸ CCNA1 P78396 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29611365 0.83 CDK1 (1.00) CDK1CDK2CCNB1CCNE1ADORA2A
SCHEMBL756644 0.83 CDK1 (1.00) CDK1CDK2CCNB1CCNE1ADORA2A
SCHEMBL784159 0.81 CDK2 (0.73) CDK1CDK2CCNB1CCNE1ADORA2A
SCHEMBL2314138 0.80 CDK1 (0.55) CDK1CDK2CCNB1CCNE1ADORA2A
SCHEMBL22700170 0.80 CDK1 (0.71) CDK1CDK2CCNB1CCNE1ADORA2A
SCHEMBL24235899 0.80 CDK2 (0.71) CDK1CDK2CCNB1CCNE1ADORA2A
SCHEMBL3441256 0.80 CDK2 (0.71) CDK1CDK2CCNB1CCNE1ADORA2A
SCHEMBL14039518 0.80 CDK1 (0.71) CDK1CDK2CCNB1CCNE1ADORA2A
SCHEMBL23641789 0.78 CDK1 (0.45) CDK1CDK2CCNB1CCNE1ADORA2A
SCHEMBL22571127 0.78 CDK2 (0.67) CDK1CDK2CCNB1CCNE1ADORA2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7989430-B2 Antibacterial agents REGENTS OF THE UNIVERSITY OF MINNESOTA (US) 2011-08-02 — — US disclosed
US-20080293666-A1 Antibacterial Agents REGENTS OF THE UNIVERSITY OF MINNESOTA (US) 2008-11-27 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20080293666-A1 Antibacterial Agents MRPL21, ABCB7, MSR1 CDK1 2791/4885CDK2 3708/4885CCNB1 193/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback